Franco Austria’s biotechnology lab Valneva announced positive results from clinical trials of COVID vaccine candidates on Monday, a month after the UK government terminated its supply contract with the company.
The UK ordered 100 million doses of vaccine from 2021 to 2022. This is the only order in Valneva so far. Production facility In Scotland.
The French government says the European Union is still in talks to buy the vaccine.
According to Barbena, a Phase 3 study of 4,012 adults in the UK showed “positive” results for the vaccine, providing more neutralizing antibodies than injections made by UK pharmaceutical giant AstraZeneca. Was done.
Valneva’s VLA2001 vaccine is based on an “inactivated” version of the coronavirus itself to prevent COVID-19.
Adam Finn, a professor of pediatrics and senior researcher at the University of Bristol, said:
“These results suggest this Vaccine candidate We are on track to play an important role in overcoming the pandemic. “
After the announcement, Valneva’s share price soared by more than 30%. They sank after Britain canceled the deal last month.
The company said it has begun a vaccine approval process with UK health regulators and is preparing to submit a request to the European Medicines Agency.
Valneva CEO Thomas Ringerbach said:
© 2021 AFP
Quote: Valneva results from a “positive” COVID vaccine obtained on October 18, 2021 from https: //medicalxpress.com/news/2021-10-valneva-positive-covid-vaccine-results.html (2021) October 18th) is reported
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.
Valneva reports ‘positive’ COVID vaccine results Source link Valneva reports ‘positive’ COVID vaccine results